Marijuana Could Be the Answer to Curing Alzheimer's Disease, Study Shows
The statistics associated with Alzheimer's disease are downright depressing.
The disease, which typically affects the elderly and is characterized by a progressive decline in cognitive function, currently afflicts 5.4 million Americans, and the Alzheimer's Association expects the direct and indirect costs of treatment to reach $236 billion in 2016. Some one in nine people over the age of 65 has Alzheimer's disease, and within the U.S., it's the sixth-leading cause of death.
These statistics are even scarier when you consider how much researchers still have to learn about this disease. Though there are medications designed to slow the progression of the various stages of the disease, a cure for Alzheimer's disease remains elusive for the time being.
A number of big-name drug developers have taken aim at Alzheimer's, only to have their studies end in disappointment. Drug giants Johnson & Johnson and Pfizer teamed up to develop bapineuzumab, while Eli Lilly developed solanezumab. Both...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin